Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

NCT07348588 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa (RP)
Extensive Macular Atrophy With Pseudodrusen (EMAP)

Interventions

DRUG: Intravitreal Adalimumab

Sponsor

Centro de Pesquisa Rubens Siqueira